BFA
CORT icon

BlackRock Fund Advisors’s Corcept Therapeutics CORT Stock Holding History

BlackRock Fund Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23.9M Buy
3,296,752
+1,221,431
+59% +$9.57M ﹤0.01% 2079
2016
Q3 		$13.5M Buy
2,075,321
+132,586
+7% +$771K ﹤0.01% 2293
2016
Q2 		$10.6M Buy
1,942,735
+329,731
+20% +$1.72M ﹤0.01% 2380
2016
Q1 		$7.55M Sell
1,613,004
-63,502
-4% -$247K ﹤0.01% 2511
2015
Q4 		$8.35M Buy
1,676,506
+60,227
+4% +$272K ﹤0.01% 2543
2015
Q3 		$6.08M Sell
1,616,279
-16,939
-1% -$86K ﹤0.01% 2681
2015
Q2 		$9.82M Buy
1,633,218
+145,954
+10% +$895K ﹤0.01% 2511
2015
Q1 		$8.33M Sell
1,487,264
-5,637
-0.4% -$20.4K ﹤0.01% 2543
2014
Q4 		$4.48M Buy
1,492,901
+189,233
+15% +$577K ﹤0.01% 2936
2014
Q3 		$3.49M Sell
1,303,668
-55,423
-4% -$147K ﹤0.01% 2950
2014
Q2 		$3.81M Sell
1,359,091
-129,124
-9% -$381K ﹤0.01% 2984
2014
Q1 		$6.49M Buy
1,488,215
+44,580
+3% +$156K ﹤0.01% 2656
2013
Q4 		$4.63M Sell
1,443,635
-65,504
-4% -$132K ﹤0.01% 2875
2013
Q3 		$2.4M Buy
1,509,139
+174,688
+13% +$308K ﹤0.01% 3095
2013
Q2 		$2.31M Buy
+1,334,451
New +$2.4M ﹤0.01% 3072

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Fund Advisors's CORT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Corcept Therapeutics (CORT) stake by 59% in Q4 2016, buying an estimated $9.57M and bringing the position to 3,296,752 shares worth $23.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

BlackRock Fund Advisors first reported a position in CORT in Q2 2013 and has held it in 15 quarters since. 135 funds tracked by Wall St. Rank hold CORT as of Q4 2016.

  • BlackRock Fund Advisors held 3,296,752 shares of Corcept Therapeutics worth $23.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,221,431 Corcept Therapeutics shares in Q4 2016, an estimated $9.57M.
  • Corcept Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2079 holding.
  • BlackRock Fund Advisors first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • 135 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.